Chiesi Farmaceutici S.p.A acquires Raptor Pharmaceutical

On May 23, 2017, Chiesi Farmaceutici S.p.A acquired Raptor Pharmaceutical, a life science company in California, United States, from Horizon Pharma plc.

Deal at a glance

AnnouncedMay 23, 2017 TypeDivestiture TargetRaptor Pharmaceutical Buyer Chiesi Farmaceutici S.p.A Seller Horizon Pharma plc SectorLife Science LocationCalifornia, United States ValueMembers only

Target company

Raptor Pharmaceutical

California, United States

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

Chiesi Farmaceutici S.p.A

Company · 2 deals on record

1st transaction in life science
2nd transaction in United States

2deals, all time

1in this sector

2017latest

Seller

Horizon Pharma plc

Company · 3 deals on record

3investments

3in this sector

1exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Raptor Pharmaceutical?Chiesi Farmaceutici S.p.A acquired Raptor Pharmaceutical on May 23, 2017.

Who sold Raptor Pharmaceutical?Horizon Pharma plc was the seller.

What type of deal was it?It was a divestiture in the life science sector in 2017.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).